对不同类型的糖尿病黄斑 edem 的蛋白质学研究
Shuang Wu1,2, Xin Zhou1, Libo Wang1
1Kunshan First People's Hospital Affiliated to Jiangsu University, Suzhou, China.
Current eye research
|July 23, 2025
概括
这项研究确定了糖尿病黄斑的亚型中的关键蛋白质差异,揭示了抗VEGF治疗对囊性黄斑退化不那么有效. 这些发现提供了对疾病机制的洞察.
科学领域:
- 眼科医生 眼科 眼科
- 蛋白质组学是指蛋白质组学.
- 分子生物学分子生物学
背景情况:
- 糖尿病黄斑 (DME) 呈现出各种形态特征,影响治疗反应.
- 了解这些特征的分子基础对于向治疗至关重要.
研究的目的:
- 识别与不同的DME形态特征相关的独特蛋白质标记物:分散的视网膜加厚,囊性黄斑胀 (CME) 和囊性黄斑变性 (CMD).
- 为了在这些DME亚型中比较水性幽默中的蛋白质概况.
- 为了将蛋白质表达与抗血管内皮生长因子 (抗VEGF) 治疗疗效相关联.
主要方法:
- 来自9名DME患者的水性幽默样本使用双重质量标签 (TMT) 定量蛋白质学进行了分析.
- 在分散的视网膜加厚,CME和CMD组之间比较了蛋白质表达特征.
- 根据折叠变化 (>1.2或<0.83) 和P值 (<0.05) 评估了差异性蛋白质表达.
主要成果:
- 与分散视网膜加厚和CME组相比,CMD组的抗VEGF治疗疗效明显较低.
- 与CMD相比,分散的视网膜加厚组显示了31个上调的蛋白质 (例如补充系统,亡过程) 和43个下调的蛋白质.
- 与CMD相比,CME组显示了31个上调的蛋白质 (例如,Wnt信号,ECM受体相互作用) 和32个下调的蛋白质.
结论:
- 形成CMD与补充系统,亡途径和脂质代谢有关.
- 蛋白质表达的差异为不同的DME形态特征的病原体提供了洞察力.
- 这些发现可能会指导未来针对特定DME亚型的治疗策略.
相关概念视频
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: